Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > Upcoming Updates
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Hideawayon Dec 01, 2021 3:14pm
145 Views
Post# 34186590

RE:RE:Upcoming Updates

RE:RE:Upcoming Updates Seems a bit to early for tax loss selling but maybe.My impression is that investors are getting weary of this stock and things could get worse if they miss the updates timelines. If we don't get updated in the next 15 to 18 days any subsequent positive news would be somewhat negated by Xmas.I believe it was a Wells Fargo report that suggested a few weeks ago that the bladder cancer results were impressive.Hope they are right although it is difficult to see how they would get this info as it would be privileged until Merck and IMV issued a release.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities